Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TESICE-RA study of rituximab effects on synovial tissue and peripheral blood B cells in rheumatoid arthritis
2007-003623-20Phase 4Active
- Sponsor
- Hospital Clínic de Barcelona
- Start
- Feb 2008
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of rituximab in rheumatoid arthritis (RA), sponsored by Hospital Clínic de Barcelona. Primary endpoints: Cellular and molecular changes induced by rituximab and Correlation of biomarker changes with clinical response. Started Feb 2008; status: active.
02
Drugs
rituximab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2007-003623-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003623-20.